PROLEVI BIO
Prolevi Bio develops a delayed-release thyroid hormone formulation mimicking the circadian rhythm improving long-term side effects.
PROLEVI BIO
Industry:
Biotechnology Health Care Medical
Founded:
2022-01-01
Address:
Limhamn, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.prolevi.bio
Total Employee:
1+
Status:
Active
Total Funding:
3 M SEK
Technology used in webpage:
One.com
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Clade Therapeutics
Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
VectivBio
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
Almi Invest
Almi Invest investment in Seed Round - Prolevi Bio
Official Site Inspections
http://www.prolevi.bio
- Host name: webcluster2.wordpresspod2-cph3.one.com
- IP address: 77.111.241.123
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Prolevi Bio"
Prolevi Bio - Transforming treatment for Hypothyroidism patients
ProLevi develops a delayed release thyroid hormone formulation mimicking the circadian rhythm. Prolevi Bio . Summary; Hypothyroidism; Solution; Team; Vision; Contact ... Prolevi Bio, Inc. c/o …See details»
Prolevi Bio - Crunchbase Company Profile & Funding
Organization. Prolevi Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Prolevi Bio …See details»
Prolevi Bio 2025 Company Profile: Valuation, Funding …
Prolevi Bio General Information Description. Developer of a biomimicking therapy designed to target metabolic disorders The company's therapy deploys …See details»
Prolevi Bio - LinkedIn
Prolevi Bio is moving forward with clinical plans to perform a T3+T4 combination trial with its controlled release T3 formulation that follows the natural hormone release cycles i.e. Circadian ...See details»
Team - Nested Bio AB
CEO, Prolevi Bio AB Sahil Gupta has a PhD from Goethe University Frankfurt with over 10 years of R&D experience in life sciences, immunology, and genetic engineering. After a short residence at Nested Bio, Sahil founded Prolevi Bio …See details»
Prolevi Bio
Prolevi is an international start-up with registered offices in Sweden. Prolevi’s platform patent technology focuses on women’s health with hypothyroidism as a first use case, due to huge …See details»
Prolevi Bio - Products, Competitors, Financials, Employees ...
Prolevi Bio raising funds The company has opened a financing seed round and aims to raise another €5 million to €6 million ($5.4-6.5 million) to finance a phase 1 study validating the …See details»
Prolevi - MVA
Prolevi is an international start-up with a long-term aim to target metabolic disorders. Women’s health is largely underfunded, and Prolevi initially addresses one of the biggest challenges, …See details»
New SmiLe company develops first effective treatment for …
May 15, 2023 Lund, Sweden – Prolevi Bio's unique technology is intended to help those 10-20 percent who don't respond to today's medicine for underactive thyroid glands. The company …See details»
Prolevi Bio develops treatment for hypothyroidism
May 19, 2023 Prolevi Bio developed a platform technology that releases the hormone according to the body’s circadian rhythm. In addition, the drug will act as a precision medicine – each patient will receive an individually adapted …See details»
Prolevi Bio AB Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Prolevi Bio AB of Limhamn, Skåne. Get the latest business insights from Dun & Bradstreet. D&B Business …See details»
Prolevi Bio (company) - Nordic 9
Prolevi Bio is a health startup from Lund, Sweden, developing biomimicking therapy for metabolic disorders Investors: we tracked 1 investor You need an account to access this feature.See details»
Prolevi Bio - Funding, Financials, Valuation & Investors - Crunchbase
Prolevi Bio develops a delayed release thyroid hormone formulation mimicking the circadian rhythm improving long-term side effects. New. Resources. ... How much funding has this …See details»
Prolevi Bio on LinkedIn: Prolevi Bio - Transforming treatment for ...
Prolevi Bio 310 followers 10mo Edited Report this post We are thrilled to announce that we recently closed a funding round with both new investors and continued participation of existing …See details»
New SmiLe company develops first effective treatment for …
May 16, 2023 Lund, Sweden – Prolevi Bio's unique technology is intended to help those 10-20 precent who don't respond to today's medicine for underactive thyroid glands. The company …See details»
Stefan Kilian on LinkedIn: Prolevi Bio - Transforming treatment for ...
Prolevi's technology of mimicking the circadian rhythm is simple, yet compelling and based on a convincing scientific rationale and data. ... Prolevi Bio - Developing the first effective treatment ...See details»
Sahil Gupta on LinkedIn: Prolevi Bio - Transforming treatment for ...
Happy to share our continued momentum towards #Women’s #Health (#Hypothyroidism, underactive thyroid), with a successful round close! Special thanks to the Prolevi Bio Team!See details»
Prolevi Bio on LinkedIn: #prolevi #clinicaltrials | 10 comments
We are excited to welcome our first hire Smera Sureshan to Prolevi Bio as Regulatory and Clinical Trial Assistant. Smera is a biotechnologist with clinical trial operations and business ...See details»
BIO International Convention Opens in Boston, Showcasing Global ...
1 day ago The world’s largest biotech gathering unites 20,000+ leaders to accelerate breakthroughs that heal, protect, and nourish humanity. BOSTON (June 16, 2025) The BIO …See details»
Nytt SmiLe-bolag utvecklar första effektiva behandlingen mot …
May 16, 2023 Nya SmiLe-bolaget Prolevi Bio utvecklar den första effektiva behandlingen mot hypotyreos, underaktiv sköldkörtel. Läkemedlet ska frisätta sköldkörtelhormon över dygnet på …See details»